4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001140361-26-024784
Options or other derivatives
- Chief Executive Officer acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Luo Ying · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-08 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +120,000 | 120,000 | D |
Loading xslF345X06/form4.xml…